Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Potential roles of gut microbiome and metabolites in modulating ALS in mice.

Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, Zabari M, Brik RB, Kviatcovsky D, Zmora N, Cohen Y, Bar N, Levi I, Amar N, Mehlman T, Brandis A, Biton I, Kuperman Y, Tsoory M, Alfahel L, Harmelin A, Schwartz M, Israelson A, Arike L, Johansson MEV, Hansson GC, Gotkine M, Segal E, Elinav E.

Nature. 2019 Aug;572(7770):474-480. doi: 10.1038/s41586-019-1443-5. Epub 2019 Jul 22.

PMID:
31330533
2.

The prognostic significance of bone marrow involvement in diffuse large B cell lymphoma according to the flow cytometry.

Greenbaum U, Levi I, Madmoni O, Lior Y, Al-Athamen K, Perry ZH, Hatzkelzon L, Shubinsky G.

Leuk Lymphoma. 2019 Oct;60(10):2477-2482. doi: 10.1080/10428194.2019.1587755. Epub 2019 Apr 24.

PMID:
31014136
3.

Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT.

Hod N, Lantsberg S, Anconina R, Levin D, Nalbandyan K, Levi I.

Clin Nucl Med. 2019 Jun;44(6):e409-e412. doi: 10.1097/RLU.0000000000002568.

PMID:
30985428
4.

Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.

Herishanu Y, Tadmor T, Braester A, Bairey O, Aviv A, Rahimi-Levene N, Fineman R, Levi I, Yuklea M, Ruchlemer R, Shvidel L, Polliack A.

Hematol Oncol. 2019 Apr;37(2):185-192. doi: 10.1002/hon.2580. Epub 2019 Mar 12.

PMID:
30756414
5.

Detection of Disseminated Aspergillosis on FDG PET/CT in a Patient with Acute Lymphoblastic Leukemia.

Hod N, Anconina R, Levin D, Tiktinsky E, Ezroh Kazap D, Levi I, Zektser M, Stavi V, Sebbag G, Lantsberg S.

Isr Med Assoc J. 2018 Nov;20(11):720-721. No abstract available.

6.

Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study.

Leader A, Gafter-Gvili A, Benyamini N, Dreyer J, Calvarysky B, Amitai A, Yarchovsky-Dolberg O, Sharf G, Tousset E, Caspi O, Ellis M, Levi I, Raanani P, De Geest S.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):e351-e362. doi: 10.1016/j.clml.2018.06.007. Epub 2018 Jun 12.

PMID:
30122203
7.

Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot Study.

Leader A, Benyamini N, Gafter-Gvili A, Dreyer J, Calvarysky B, Amitai A, Yarchovsky-Dolberg O, Sharf G, Tousset E, Caspi O, Ellis M, Levi I, De Geest S, Raanani P.

Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e449-e461. doi: 10.1016/j.clml.2018.06.026. Epub 2018 Jun 25.

PMID:
30030034
8.

Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?

Greenbaum U, Joffe E, Filanovsky K, Oster HS, Kirgner I, Levi I, Raanani P, Avivi I, Manor E, Man-El G, Mittelman M.

Eur J Haematol. 2018 Oct;101(4):502-507. doi: 10.1111/ejh.13134. Epub 2018 Aug 31.

PMID:
29956845
9.

The association between otogenic lateral sinus thrombosis and thrombophilia - A long-term follow-up.

Schneider S, Kapelushnik J, Kraus M, El Saied S, Levi I, Kaplan DM.

Am J Otolaryngol. 2018 May - Jun;39(3):299-302. doi: 10.1016/j.amjoto.2018.03.013. Epub 2018 Mar 7.

PMID:
29530427
10.

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.

Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L.

Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16.

PMID:
29456043
11.

Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature.

Shkalim-Zemer V, Levi I, Fischer S, Tamary H, Yakobovich J, Avrahami G, Gilad G, Elitzur S, Yaniv I, Elhasid R, Manistersky M, Shalit I.

Pediatr Infect Dis J. 2018 Jul;37(7):686-690. doi: 10.1097/INF.0000000000001844. Review.

PMID:
29140934
12.

Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.

Falik-Zaccai TC, Barsheshet Y, Mandel H, Segev M, Lorber A, Gelberg S, Kalfon L, Ben Haroush S, Shalata A, Gelernter-Yaniv L, Chaim S, Raviv Shay D, Khayat M, Werbner M, Levi I, Shoval Y, Tal G, Shalev S, Reuveni E, Avitan-Hersh E, Vlodavsky E, Appl-Sarid L, Goldsher D, Bergman R, Segal Z, Bitterman-Deutsch O, Avni O.

EMBO Mol Med. 2017 Sep;9(9):1326. doi: 10.15252/emmm.201708209. No abstract available.

13.

Dimensional changes of the maxillary sinus following tooth extraction in the posterior maxilla with and without socket preservation.

Levi I, Halperin-Sternfeld M, Horwitz J, Zigdon-Giladi H, Machtei EE.

Clin Implant Dent Relat Res. 2017 Oct;19(5):952-958. doi: 10.1111/cid.12521. Epub 2017 Jul 26.

PMID:
28745002
14.

Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.

Falik-Zaccai TC, Barsheshet Y, Mandel H, Segev M, Lorber A, Gelberg S, Kalfon L, Ben Haroush S, Shalata A, Gelernter-Yaniv L, Chaim S, Raviv Shay D, Khayat M, Werbner M, Levi I, Shoval Y, Tal G, Shalev S, Reuveni E, Avitan-Hersh E, Vlodavsky E, Appl-Sarid L, Goldsher D, Bergman R, Segal Z, Bitterman-Deutsch O, Avni O.

EMBO Mol Med. 2017 Mar;9(3):319-336. doi: 10.15252/emmm.201606523. Erratum in: EMBO Mol Med. 2017 Sep;9(9):1326.

15.

Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study.

Cohen YC, Zuckerman T, Yeshurun M, Perez G, Magen H, Henig I, Levi I, Shargian L, Trestman S, Rouvio U, Naparstek E, Ganon-Elazar E, Avivi I, Ram R.

Ann Hematol. 2017 Feb;96(2):271-278. doi: 10.1007/s00277-016-2882-9. Epub 2016 Dec 30.

PMID:
28039512
16.

Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I.

Shalev H, Al-Athamen K, Levi I, Levitas A, Tamary H.

Eur J Haematol. 2017 Jan;98(1):13-18. doi: 10.1111/ejh.12778. Epub 2016 Jun 15.

PMID:
27206021
17.

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.

Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, Antoniadou A, Carmeli Y, Nutman A, Levi I, Adler A, Durante-Mangoni E, Andini R, Cavezza G, Mouton JW, Wijma RA, Theuretzbacher U, Friberg LE, Kristoffersson AN, Zusman O, Koppel F, Dishon Benattar Y, Altunin S, Paul M; AIDA consortium.

BMJ Open. 2016 Apr 20;6(4):e009956. doi: 10.1136/bmjopen-2015-009956.

18.

Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.

Admoni-Elisha L, Nakdimon I, Shteinfer A, Prezma T, Arif T, Arbel N, Melkov A, Zelichov O, Levi I, Shoshan-Barmatz V.

PLoS One. 2016 Apr 14;11(4):e0148500. doi: 10.1371/journal.pone.0148500. eCollection 2016.

19.

Bowel preparation in "real-life" small bowel capsule endoscopy: a two-center experience.

Klein A, Dashkovsky M, Gralnek I, Peled R, Chowers Y, Khamaysi I, Har-Noy O, Levi I, Nadler M, Eliakim R, Kopylov U.

Ann Gastroenterol. 2016 Apr-Jun;29(2):196-200. doi: 10.20524/aog.2016.0012.

20.

Glatiramer Acetate-associated Refractory Immune Thrombocytopenic Purpura.

Sagy I, Shalev L, Levi I, Shleyfer E, Valdman S, Barski L.

Eur J Case Rep Intern Med. 2016 Jan 27;3(3):000399. doi: 10.12890/2016_000399. eCollection 2016.

21.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

22.

High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.

Kedmi M, Apel A, Davidson T, Levi I, Dann EJ, Polliack A, Ben-Bassat I, Nagler A, Avigdor A.

Acta Haematol. 2016;135(3):156-61. doi: 10.1159/000441962. Epub 2015 Nov 21.

PMID:
26588173
23.

Diurnal and seasonal variation of cough episodes in healthy young adults.

Zigel Y, Goldbart A, Freud T, Erew A, Abu Leil M, Tocker Y, Levi I, Urkin J.

J Asthma. 2016;53(3):295-300. doi: 10.3109/02770903.2015.1087557. Epub 2015 Oct 29.

PMID:
26513001
24.

Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single center.

Houri I, Tzukert K, Levi IM, Aharon M, Bloch A, Gotsman O, Backenroth R, Levi R, Dov IB, Rubinger D, Elhalel MD.

Diabetol Metab Syndr. 2015 Oct 16;7:90. doi: 10.1186/s13098-015-0083-7. eCollection 2015.

25.

Characterization of tumor infiltrating natural killer cell subset.

Levi I, Amsalem H, Nissan A, Darash-Yahana M, Peretz T, Mandelboim O, Rachmilewitz J.

Oncotarget. 2015 May 30;6(15):13835-43.

26.

The effect of medical students' gender, ethnicity and attitude towards poetry-reading on the evaluation of a required, clinically-integrated poetry-based educational intervention.

Muszkat M, Barak O, Lalazar G, Mazal B, Schneider R, Levi IM, Cohen MJ, Canetti L, Ben Yehuda A, Naparstek Y.

BMC Med Educ. 2014 Sep 15;14:188. doi: 10.1186/1472-6920-14-188.

27.

Methylprednisolone-induced liver injury: a diagnostic challenge.

Melamud B, Lurie Y, Goldin E, Levi I, Esayag Y.

Isr Med Assoc J. 2014 Mar;16(3):180-1. No abstract available.

28.

Remission of long-standing alopecia universalis after human immunodeficiency virus infection.

Ramot Y, Tetro T, Levi I, Zlotogorski A.

Clin Exp Dermatol. 2014 Apr;39(3):399-400. doi: 10.1111/ced.12260. Epub 2014 Jan 23. No abstract available.

PMID:
24450742
29.

Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel.

Levi I, Feuchtwanger M, Rabinovich A, Grotto I.

Springerplus. 2013 Dec 16;2:672. doi: 10.1186/2193-1801-2-672. eCollection 2013.

30.

Obstetric outcomes after restrictive bariatric surgery: what happens after 2 consecutive pregnancies?

Amsalem D, Aricha-Tamir B, Levi I, Shai D, Sheiner E.

Surg Obes Relat Dis. 2014 May-Jun;10(3):445-9. doi: 10.1016/j.soard.2013.08.016. Epub 2013 Sep 19.

PMID:
24342035
31.

VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.

Mendel I, Feige E, Yacov N, Salem Y, Levi I, Propheta-Meiran O, Shoham A, Ishai E, George J, Harats D, Breitbart E.

Clin Exp Immunol. 2014 Jan;175(1):126-37. doi: 10.1111/cei.12212.

32.

VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.

Prezma T, Shteinfer A, Admoni L, Raviv Z, Sela I, Levi I, Shoshan-Barmatz V.

Cell Death Dis. 2013 Sep 19;4:e809. doi: 10.1038/cddis.2013.316.

33.

Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.

Feige E, Yacov N, Salem Y, Levi I, Mendel I, Propheta-Meiran O, Shoham A, Hait-Darshan R, Polonsky O, George J, Harats D, Breitbart E.

Atherosclerosis. 2013 Aug;229(2):430-9. doi: 10.1016/j.atherosclerosis.2013.06.005. Epub 2013 Jun 21.

34.

Pregnancy outcome of patients following bariatric surgery as compared with obese women: a population-based study.

Shai D, Shoham-Vardi I, Amsalem D, Silverberg D, Levi I, Sheiner E.

J Matern Fetal Neonatal Med. 2014 Feb;27(3):275-8. doi: 10.3109/14767058.2013.814632. Epub 2013 Jul 18.

PMID:
23773032
35.

Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.

Cohen MJ, Bloom AI, Barak O, Klimov A, Nesher T, Shouval D, Levi I, Shibolet O.

World J Gastroenterol. 2013 Apr 28;19(16):2521-8. doi: 10.3748/wjg.v19.i16.2521.

36.

Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects.

Levi I, Eskira Y, Eisenstein M, Gilon C, Hoffman A, Tal-Gan Y, Fanous J, Bersudsky Y, Belmaker RH, Agam G, Almog O.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1806-15. doi: 10.1016/j.euroneuro.2013.02.004. Epub 2013 Apr 22. Erratum in: Eur Neuropsychopharmacol. 2015 Nov;25(11):2185. Talgan, Yiftach [corrected to Tal-Gan, Yftah].

PMID:
23619164
37.

Erythrocyte swelling and membrane hole formation in hypotonic media as studied by conductometry.

Pribush A, Meyerstein D, Hatskelzon L, Kozlov V, Levi I, Meyerstein N.

Physiol Meas. 2013 Feb;34(2):139-50. doi: 10.1088/0967-3334/34/2/139. Epub 2013 Jan 23.

PMID:
23343529
38.

High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I.

Shalev H, Perez-Avraham G, Kapelushnik J, Levi I, Rabinovich A, Swinkels DW, Brasse-Lagnel C, Tamary H.

Eur J Haematol. 2013 Jan;90(1):31-6. doi: 10.1111/ejh.12027. Epub 2012 Dec 4.

PMID:
23095116
39.

Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.

Vazana-Barad L, Granot G, Mor-Tzuntz R, Levi I, Dreyling M, Nathan I, Shpilberg O.

Leuk Lymphoma. 2013 Apr;54(4):851-9. doi: 10.3109/10428194.2012.734614. Epub 2013 Jan 2.

PMID:
23020673
40.

Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management.

Gurevich M, Levi I, Steinberg R, Shonfeld T, Shapiro R, Israeli M, Sprecher H, Shalit I, Mor E.

Transpl Infect Dis. 2012 Oct;14(5):E97-101. doi: 10.1111/j.1399-3062.2012.00776.x. Epub 2012 Aug 16.

PMID:
22897560
41.

Primary Refractory and Relapsed Classical Hodgkin Lymphoma - Significance of Differential CD15 Expression in Hodgkin-Reed-Sternberg Cells.

Benharroch D, Pilosof S, Gopas J, Levi I.

J Cancer. 2012;3:322-7. doi: 10.7150/jca.4716. Epub 2012 Jul 24.

42.

Dexrazoxane does not affect treatment outcome in non-Hodgkin's lymphoma patients.

Rabinovich A, Weiss D, Weissman M, Novack V, Levi I.

Am J Hematol. 2012 Aug;87(8):830-2. doi: 10.1002/ajh.23250. Epub 2012 May 31. No abstract available.

43.

Downsizing pregnancy complications: a study of paired pregnancy outcomes before and after bariatric surgery.

Aricha-Tamir B, Weintraub AY, Levi I, Sheiner E.

Surg Obes Relat Dis. 2012 Jul-Aug;8(4):434-9. doi: 10.1016/j.soard.2011.12.009. Epub 2011 Dec 24.

PMID:
22301092
44.

A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.

Shimoni A, Avivi I, Rowe JM, Yeshurun M, Levi I, Or R, Patachenko P, Avigdor A, Zwas T, Nagler A.

Cancer. 2012 Oct 1;118(19):4706-14. doi: 10.1002/cncr.27418. Epub 2012 Jan 17.

45.

Type 1 diabetes affects topoisomerase I activity and GlcNAcylation in rat organs: kidney, liver and pancreas.

Levi I, Segev Y, Priel E.

Glycobiology. 2012 May;22(5):704-13. doi: 10.1093/glycob/cws008. Epub 2012 Jan 12.

PMID:
22247452
46.

Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC.

Koren-Michowitz M, Volchek Y, Naparstek E, Gavish I, Levi I, Rowe JM, Shimoni A, Nagler A.

Hematol Oncol. 2012 Dec;30(4):200-5. doi: 10.1002/hon.2005. Epub 2012 Jan 12.

PMID:
22241698
47.

Cells exposed to sublethal oxidative stress selectively attract monocytes/macrophages via scavenger receptors and MyD88-mediated signaling.

Geiger-Maor A, Levi I, Even-Ram S, Smith Y, Bowdish DM, Nussbaum G, Rachmilewitz J.

J Immunol. 2012 Feb 1;188(3):1234-44. doi: 10.4049/jimmunol.1101740. Epub 2012 Jan 4.

48.

Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study.

Yom-Tov G, Nathan I, Shpilberg O, Polliack A, Levi I.

Leuk Res. 2012 Jan;36(1):42-5. doi: 10.1016/j.leukres.2011.08.015. Epub 2011 Oct 4.

PMID:
21974857
49.

Chronic myelogenous leukemia diagnosed in two patients with breast cancer.

Abu-Ghanem S, Rabinovich A, Delgado B, Benharroch D, Ariad S, Levi I, Geffen DB.

Leuk Lymphoma. 2011 Dec;52(12):2399-401. doi: 10.3109/10428194.2011.600483. Epub 2011 Aug 18. No abstract available.

PMID:
21851217
50.

Low dose palliative radiotherapy for splenomegaly in hematologic disorders.

Lavrenkov K, Krepel-Volsky S, Levi I, Ariad S.

Leuk Lymphoma. 2012 Mar;53(3):430-4. doi: 10.3109/10428194.2011.614708. Epub 2011 Sep 23.

PMID:
21848363

Supplemental Content

Support Center